Innovative Eyewear (LUCY) Stock Price, News & Analysis

Company Overview

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

Key Stats

• Today's Range: $1.97 to $2.00
• 50-Day Range: $1.92 to $3.53
• 52-Week Range: $1.57 to $11.16
• Volume: 44,508 shs
• Average Volume: 1.22 million shs
• Market Capitalization: $6.55 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Innovative Eyewear Stock Analysis - MarketRank™

Innovative Eyewear scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Innovative Eyewear.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Innovative Eyewear is -0.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Innovative Eyewear is -0.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Innovative Eyewear has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

7.52% of the float of Innovative Eyewear has been sold short.

Short Interest Ratio / Days to Cover

Innovative Eyewear has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Innovative Eyewear has recently decreased by 30.24%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Innovative Eyewear does not currently pay a dividend.

Dividend Growth

Innovative Eyewear does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

7.52% of the float of Innovative Eyewear has been sold short.

Short Interest Ratio / Days to Cover

Innovative Eyewear has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Innovative Eyewear has recently decreased by 30.24%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for LUCY on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Innovative Eyewear insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.66% of the stock of Innovative Eyewear is held by insiders.

Percentage Held by Institutions

Only 0.96% of the stock of Innovative Eyewear is held by institutions.

LUCY Stock Analysis - Frequently Asked Questions

How have LUCY shares performed this year?

Innovative Eyewear's stock was trading at $4.92 at the start of the year. Since then, LUCY shares have decreased by 59.9% and is now trading at $1.9750.

How were Innovative Eyewear's earnings last quarter?

Innovative Eyewear, Inc. (NASDAQ:LUCY) released its earnings results on Thursday, August, 14th. The company reported ($0.66) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.77) by $0.11. The company had revenue of $0.58 million for the quarter, compared to analyst estimates of $1 million. Innovative Eyewear had a negative trailing twelve-month return on equity of 79.72% and a negative net margin of 390.70%.

When did Innovative Eyewear's stock split?

Innovative Eyewear shares reverse split before market open on Thursday, July 18th 2024.The 1-20 reverse split was announced on Thursday, July 18th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 18th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Innovative Eyewear IPO?

Innovative Eyewear (LUCY) raised $8 million in an IPO on the week of August 15th 2022. The company issued 900,000 shares at a price of $7.50-$9.50 per share. Maxim Group acted as the underwriter for the IPO.

Who are Innovative Eyewear's major shareholders?

Top institutional investors of Innovative Eyewear include Cetera Investment Advisers (3.41%). Insiders that own company stock include Vladimir Galkin and Harrison R Gross.
View institutional ownership trends.

How do I buy shares of Innovative Eyewear?

Shares of LUCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Innovative Eyewear own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Innovative Eyewear investors own include Sangamo Therapeutics (SGMO), Meta Platforms (META), NVIDIA (NVDA), Faraday Future Intelligent Electric (FFIE), NIO (NIO) and Verizon Communications (VZ).

Company Calendar

• Last Earnings: 8/14/2025
• Today: 8/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:LUCY
• CIK: 1808377
• Web: www.lucyd.co
• Phone: 786-785-5178
• Fax: N/A
• Employees: 9
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($2.78)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.77 million
• Net Margins: -390.70%
• Pretax Margin: -390.75%
• Return on Equity: -79.72%
• Return on Assets: -74.86%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 18.70
• Quick Ratio: 15.46

Sales & Book Value

• Annual Sales: $1.64 million
• Price / Sales: 3.98
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.72 per share
• Price / Book: 0.53

Miscellaneous

• Outstanding Shares: 3,300,000
• Free Float: 3,244,000
• Market Cap: $6.53 million
• Optionable: Not Optionable
• Beta: 3.21